Product Information

PREGABALIN 225 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.0692 per EA under NDC 69238131609. Its NADAC has been published 379 times since Aug 21, 2019.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 225 MG CAPSULE

Pregabalin
$0.0692per EA
DEA Schedule CV

Strength

225 mg/1

NDC

69238131609

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA209743

FDA Approved

7/19/2019

TE Code

AB

On Market Since

7/19/2019

Price Statistics

The NADAC for PREGABALIN 225 MG CAPSULE has been published 379 times since Aug 21, 2019, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0692 per EA
All-time high$0.2382 (Sep 11, 2019)
All-time low$0.0529 (Nov 20, 2024)
52-week high$0.0692
52-week low$0.0543
Median price$0.0892
Average price$0.1049
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked379
Tracking sinceAug 21, 2019

Price History

1W

+1.3%

1M

+9.0%

3M

+23.1%

6M

+24.5%

1Y

+5.8%

3Y

-11.7%

5Y

-37.3%

All

-70.9%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 225 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $0.0692 per EA (NDC 69238131609), effective Nov 18, 2026.

How has the price of PREGABALIN 225 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 70.9%. It has been tracked across 379 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?

Since Aug 21, 2019, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0529 (Nov 20, 2024) to a high of $0.2382 (Sep 11, 2019), with a median of $0.0892 per EA.

Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 225 MG CAPSULE, is $0.0609 per EA — about 12% below PREGABALIN 225 MG CAPSULE.

Who manufactures PREGABALIN 225 MG CAPSULE?

PREGABALIN 225 MG CAPSULE (NDC 69238131609) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.